ArticleInternational journal of molecular sciences2025

Switch from Ibalizumab to Lenacapavir in a Rescue Regimen for a Heavily Treatment-Experienced (HTE) Patient with Multidrug-Resistant (MDR) HIV-1 Infection.

Salvatore Martini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.